Full Description
Drug therapy as an alternative to surgical intervention is becoming increasingly common. In the past five years, new anti-glaucoma agents have becoming increasingly effective. This edition will include new information on off-label prescribing and cap colors where they are mandated by the FDA (pink/white for steroid drops, grey for topical NSAIDS, etc.);There are now several new pharmaceutical agents being used to treat retinal diseases such as age-related macular degeneration (Macugen, Lucentis, Visudyne), while other drugs formerly prescribed have now been shown to be less effective. Intraocular infections are primarily treated with intravitreal medications. Additionally, the anti-allergy and dry eye markets continue to grow, with a new formulation of Allergan's Acular 0.5% (ketorolac tromethamine) and Elestat ophthalmic solution, its new antihistamine-mast cell stabilizer.
Contents
Antibacterial Agents.- Antifungal Agents.- Antiviral Agents.- Antiparasitic Agents.- Antiglaucoma Agents.- Neuro-ophthalmology.- Retina.- Antiinflammatory Agents.- Mydriatics, Cycloplegics, and Reversal Agents.- Lubricants and Viscoelastics.- Miscellaneous (Appendices) Topical Antibacterial Spectrum.- Preparing Fortified Topical Antibiotics and Oral Acetazolamide Solution.- Antifungal Activity Spectrum.- Renal Dosing for Selected Drugs.- Glaucoma Medication Preservatives.- Product Index.- Subject Index.
